Valuation: Stereotaxis, Inc.

Market Cap 103M 92.6M 85.61M 77.54M 145M 9.83B 147M 1.02B 408M 5.14B 387M 379M 16.33B P/E 2026 *
-5.07x
P/E 2027 * -7.02x
Enterprise Value 103M 92.6M 85.61M 77.54M 145M 9.83B 147M 1.02B 408M 5.14B 387M 379M 16.33B EV / Sales 2026 *
3.01x
EV / Sales 2027 * 2.26x
Free-Float
84.79%
Yield 2026 *
-
Yield 2027 * -
1 day-3.40%
1 week+0.17%
Current month-18.98%
1 month-20.90%
3 months-22.14%
6 months-46.42%
Current year-56.67%
1 week 0.98
Extreme 0.9801
1.04
1 month 0.95
Extreme 0.95
1.29
Current year 0.95
Extreme 0.95
2.86
1 year 0.95
Extreme 0.95
3.04
3 years 0.95
Extreme 0.95
3.59
5 years 0.95
Extreme 0.95
7.22
10 years 0.47
Extreme 0.47
10.3
Manager TitleAgeSince
Chief Executive Officer - 03/02/2017
Director of Finance/CFO 57 01/10/2019
Chief Operating Officer - -
Director TitleAgeSince
Chairman - 03/02/2017
Director/Board Member 70 03/02/2017
Director/Board Member 71 29/09/2016
Date Insider Type Main position Quantity % Market Cap. Importance
1/7/26 Free

Director

43,103 0.0441%
1/7/26 Free

Director

43,103 0.0441%
1/7/26
DAFNA Capital Management LLC
OtherCompany 0 0% -
Change 5-day change 1-year change 3-year change Capi.($)
-3.20%+0.17%-66.44%-32.20% 103M
+1.67%+1.44%+26.25%+62.18% 256B
+1.24%+0.39%+8.24%+26.83% 163B
+0.35%+4.49%-17.98%+73.06% 155B
-3.97%-2.64%-57.08%-13.42% 65.3B
+0.88%+3.48%+11.30%+46.70% 52.35B
+1.72%+2.11%-12.83%-6.95% 51.93B
+1.13%-1.40%+8.48%+66.10% 50.75B
+2.10%+1.89%+24.18%+79.02% 50.04B
+1.88%+4.51%+38.20%+101.99% 46.03B
Average +0.37%+1.88%-3.77%+40.33% 89.05B
Weighted average by Cap. +0.90%+1.68%+5.48%+50.32%

Financials

2026 *2027 *
Net sales 34.33M 30.8M 28.48M 25.79M 48.19M 3.27B 48.77M 341M 136M 1.71B 129M 126M 5.43B 45.67M 40.97M 37.88M 34.31M 64.09M 4.35B 64.87M 453M 180M 2.28B 171M 168M 7.23B
Net income -20.13M -18.06M -16.7M -15.13M -28.26M -1.92B -28.6M -200M -79.53M -1B -75.55M -73.96M -3.19B -14.77M -13.25M -12.25M -11.09M -20.73M -1.41B -20.98M -146M -58.33M -736M -55.41M -54.24M -2.34B
Net Debt - -
Projected Income Statement - Annual - Stereotaxis, Inc.
Logo Stereotaxis, Inc.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, it offers its customers x-ray systems and other accessory devices. It also provides robotic technologies for interventional cardiology and neuro-interventions. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters.
Employees
131
Date Price Change Volume
29/10/26 US$0.9966 -3.24% 114,285
27/10/26 US$1.030 +4.04% 565,945
26/10/26 US$0.9900 -2.94% 328,787
23/10/26 US$1.020 +2.20% 421,222
22/10/26 US$0.9980 +0.31% 381,713
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Stereotaxis, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.030USD
Average target price
3.000USD
Spread / Average Target
+191.26%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Stereotaxis, Inc.
  1. Stock Market
  2. Stocks
  3. STXS Stock